Reviewed by MSAA Chief Medical Officer Barry A. Hendin, MD In this Article Two studies highlight the beneficial role of diet in managing MS Danish study identifies how gender affects disease course in relapsing MS Can intravaginal estrogen help improve bladder dysfunction symptoms? A neurologist-patient gap in perceptions of cognitive impairment presence and severity Study: […]

Reviewed by MSAA Chief Medical Officer Barry A. Hendin, MD In this Article Cut dietary fat to cut daily fatigue, according to a new study Assessing the impact of obesity and depression on people with MS Evidence of neuroprotective effects from stem cell transplant in progressive MS Change in brain volume on MRI predicts disease […]

Reviewed by MSAA Chief Medical Officer Barry A. Hendin, MD In this Article Assessing the impact of disease-modifying therapies on COVID-19 vaccine response Shining a light on fatigue in MS Advances in new imaging technique detect metabolic changes in brain Room for improvement in current approach to performing magnetic resonance imaging Serum neurofilament light chain […]

Reviewed by MSAA Chief Medical Officer Barry A. Hendin, MD In this Article More evidence on the benefits of starting DMTs sooner rather than later Assessing the impact of Ocrevus® on patients with early-stage relapsing-remitting MS Investigational agent ublituximab lowers relapse rate in two Phase III studies Study details tolebrutinib efficacy, safety profile over 48 […]

Reviewed by MSAA Chief Medical Officer Barry A. Hendin, MD In this Article Encouraging results from Phase II study of tolebrutinib FDA authorizes stem cell trial focused on people with mild-to-moderate MS Long-term study shows sustained efficacy, consistent safety profile for Tecfidera® No short-term increase in relapse risk from Pfizer/BioNTech COVID vaccine, study finds Government […]